
Tilray Brands, Inc. (NASDAQ:TLRY) shares gained ground on Thursday after the marijuana company’s medical division expanded its portfolio in Germany with three newly certified cannabis strains.
The launch marks another step in the company's efforts to expand its European presence and offer physicians and patients more treatment options within the German medical framework.